SCHEMBL14477641

SCHEMBL14477641

CCc1ccc(S(=O)(=O)c2ccc(Oc3ccc(C(C)(C)c4ccc(C)cc4)cc3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
BCHE P06276 4/20 0.45
ACHE P22303 4/20 0.45
GAA P10253 1/20 0.44
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NR3C1 P04150 1/20 0.40
CA2 P00918 1/20 0.39
FFAR1 O14842 1/20 0.39
HSD11B1 P28845 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13670317 1.00 HTT (0.55) HTTSMN1; SMN2TDP1L3MBTL1BCHE
SCHEMBL822855 0.90 HTT (0.56) HTTSMN1; SMN2TDP1L3MBTL1BCHE
SCHEMBL13670315 0.90 HTT (0.67) HTTSMN1; SMN2TDP1L3MBTL1BCHE
SCHEMBL21572691 0.90 HTT (0.67) HTTSMN1; SMN2TDP1L3MBTL1BCHE
SCHEMBL12769543 0.90 HTT (0.67) HTTSMN1; SMN2TDP1L3MBTL1BCHE
SCHEMBL822791 0.90 HTT (0.67) HTTSMN1; SMN2TDP1L3MBTL1BCHE
SCHEMBL10030476 0.90 HTT (0.67) HTTSMN1; SMN2TDP1L3MBTL1BCHE
SCHEMBL24968065 0.89 PKM (0.53) HTTSMN1; SMN2BCHEACHEGAA
SCHEMBL10030393 0.88 TEAD4 (0.42) HTTSMN1; SMN2TDP1ALDH1A1MAPT
SCHEMBL12755539 0.88 HTT (0.40) HTTSMN1; SMN2TDP1L3MBTL1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130004887-A1 HOLOGRAPHIC RECORDING MEDIUM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2013-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130004887-A1 HOLOGRAPHIC RECORDING MEDIUM NEFM, NNMT, NOX5 HTT 840/4885SMN1; SMN2 2228/4885TDP1 871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.